Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

Researchers unveil the first 48-channel high-throughput SPR platform, enabling primary screening of large molecular libraries with high-resolution binding data, 12-fold higher throughput, and minimal ...

Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for both traditional and AI-based drug discoveryEnables ...

With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology ...

Curious about how protein crystallography fits into modern drug discovery? In this on-demand webinar, Dr. Thomas Pesnot from Concept Life Sciences chats with Dr. Debanu Das of Accelero Biostructure, ...

High-throughput mass spectrometry (HT-MS) has emerged as an indispensable tool in drug discovery, offering rapid, sensitive and label‐free detection of biochemical transformations. By coupling ...

Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...

From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...

A novel optogenetic screening platform enables control over previously intractable biological systems. Using the screening platform, scientists have been able to selectively activate the integrated ...

Molecular glues offer transformative solutions for complex diseases, targeting previously “undruggable” proteins. Key opportunities include their application in oncology, CNS disorders, and precision ...

Image-based high-content screening enables drug discovery by quantifying cellular changes. With growing use of 3D spheroid ...